Back to search
FDAFDA · Food and drugs·Recall number D-0451-2017

Flucanozole Tablets, USP, 150 mg, 12x1 Blister cards, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 India --- NDC 55111-145-12

Published February 8, 2017 · Recall initiated: December 28, 2016

Summary

FDA records drug Class II recall D-0451-2017, published February 8, 2017 and initiated December 28, 2016. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 59,440 blister cards; Lot: C500222, C500515, and C500517, exp 12/2016, C502343, exp 03/2017. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications; 18 month stability time point

What to do

Voluntary: Firm initiated · Letter

Get an email if FLUCONAZOLE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FLUCONAZOLE
Manufacturer
Dr. Reddy's Laboratories, Inc.
Distributor
Nationwide
UPC
0355111145127
Lot
C500222, C500515, and C500517, exp 12/2016, C502343, exp 03/2017
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Flucanozole Tablets, USP, 150 mg, 12x1 Blister cards, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 India --- NDC 55111-145-12 recalled?

Yes. FDA published recall D-0451-2017 on February 8, 2017. Reported hazard: Failed Dissolution Specifications; 18 month stability time point

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FLUCONAZOLE. UPC: 0355111145127.